Business Standard

Structural changes in GST

Correction to revenue-neutral rate must not be delayed

Nirmala Sitharaman
Premium

Finance Minister Nirmala Sitharaman | Illustration: Binay Sinha

Business Standard Editorial Comment Mumbai
The Goods and Services Tax (GST) Council’s 45th meeting in Lucknow last week took several important decisions and set the ball rolling for two structural changes. The council extended concessional rates for several drugs, such as Remdesivir, used to treat Covid-19. It also reduced duty on some other drugs like Itolizumab and Posaconazole till December. Since the pandemic is unlikely to end by December, the council could have easily extended the concession at least till the end of this fiscal year. It further decided to correct the inverted duty structure in textile and footwear, which was discussed in earlier meetings.

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in